| First Author | Catela C | Year | 2010 |
| Journal | Dev Dyn | Volume | 239 |
| Issue | 8 | Pages | 2149-60 |
| PubMed ID | 20568246 | Mgi Jnum | J:161794 |
| Mgi Id | MGI:4461350 | Doi | 10.1002/dvdy.22345 |
| Citation | Catela C, et al. (2010) Serum and glucocorticoid-inducible kinase 1 (SGK1) is necessary for vascular remodeling during angiogenesis. Dev Dyn 239(8):2149-60 |
| abstractText | The unquestionable importance of the cardiovascular system for pre- and postnatal life has prompted dissection of the molecular mechanisms underlying its development. Serum and glucocorticoid-inducible kinase 1 (SGK1) is a serine/threonine kinase lying downstream of the phosphoinositide 3 (PI3) kinase pathway, whose embryonic function remains unknown. Here, we show that disruption of Sgk1 in the mouse C57BL/6J genetic background leads to embryonic lethality at embryonic day 10.5-11.5 due to severe embryonic and extraembryonic angiogenic defects and to impaired myocardial trabeculation. Absence of SGK1 results in increased apoptosis of endothelial cells, and of vascular smooth muscle cells highlighting a prosurvival role for SGK1 during angiogenesis. Sgk1 null embryos also display reduced expression levels of Notch signaling genes and decreased expression of the arterial markers Efnb2 and Nrp1. These findings uncover a novel and essential function for SGK1 in cardiovascular development contributing to a better understanding of mammalian angiogenesis. |
